| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Isorhamnetin | Acute Lung Injury | 1 | PM | 35306954 | 📋 | Isorhamnetin alleviates lipopolysaccharide-induced acute lung injury by inhibiting mTOR signaling pathway |
| Isorhamnetin | Airways Inflammation | 1 | PM | 35401244 | 📋 | Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD |
| Isorhamnetin | Asthma | 1 | PM | 32865318 | 📋 | Isorhamnetin attenuates TNF-α-induced inflammation, proliferation, and migration in human bronchial epithelial cells via MAPK and NF-κB pathways |
| Isorhamnetin | COPD | 1 | PM | 35401244 | 📋 | Isorhamnetin Alleviates Airway Inflammation by Regulating the Nrf2/Keap1 Pathway in a Mouse Model of COPD |
| Isorhamnetin | Oral Cancer | 1 | PM | 32654232 | 📋 | Isorhamnetin induces the paraptotic cell death through ROS and the ERK/MAPK pathway in OSCC cells |
| Isorhamnetin | Pneumonia | 1 | PM | 37839759 | 📋 | Isorhamnetin as a novel inhibitor of pneumolysin against Streptococcus pneumoniae infection in vivo/in vitro |
| Isorhamnetin | Pulmonary Hypertension | 1 | PM | 32452118 | 📋 | Protective effects of isorhamnetin on pulmonary arterial hypertension: in vivo and in vitro studies |
